A dosimetric analysis of tomotherapy based intensity modulated radiation therapy with and without bone marrow sparing in gynecologic malignancies

Technology in Cancer Research and Treatment

Volumn 12, Issue 1, 2013, Pages 19-29

  Platta, Christopher S ^a   Bayliss, Adam ^a   McHaffie, Derek ^a   Tomé, Wolfgang A ^a   Straub, Margaret R ^a   Bradley, Kristin A ^a  

^a University of Wisconsin Health   (United States)

Author keywords

Bone marrow sparing; Cervical cancer; Endometrial cancer; IMRT; Tomotherapy

Indexed keywords

ARTICLE; BLADDER; BONE MARROW; CLINICAL ARTICLE; FEMALE; GYNECOLOGIC CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RECTUM; SMALL INTESTINE; TOMOTHERAPY; TUMOR VOLUME; UTERINE CERVIX CANCER; WILCOXON SIGNED RANKS TEST;

EID: 84873702938     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.7785/tcrt.2012.500300     Document Type: Article

References (22)

1. Thomas, G. M. Improved treatment for cervical cancer-concurrent chemotherapy and radiotherapy. N Engl J Med 340, 1198-1200 (1999). DOI: 10.1056/NEJM199904153401509
2. Keys, H. M., Bundy, B. N., Stehman, F. B., Muderspach, L. I., Chafe, W. E., Suggs, C. L., Walker, J. L., Gersell, D. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340, 1154-1161 (1999). DOI: 10.1056/NEJM199904153401503
3. Morris, M., Eifel, P. J., Lu, J., Grigsby, P. W., Levenback, C., Stevens, R. E., Rotman, M., Gershenson, D. M., Mutch, D. G. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340, 1137-1143 (1999). DOI: 10.1056/NEJM199904153401501
4. Rose, P. G., Bundy, B. N., Watkins, E. B., Thigpen, J. T., Deppe, G., Maiman, M. A., Clarke-Pearson, D. L., Insalaco, S. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340, 1144-1153 (1999). DOI: 10.1056/NEJM199904153401502
5. Green, J. A., Kirwan, J. M., Tierney, J. F., Symonds, P., Fresco, L., Collingwood, M., Williams, C. J. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358, 781-786 (2001). DOI: 10.1016/S0140-6736(01)05965-7
6. Abu-Rustum, N. R., Lee, S., Correa, A., Massad, L. S. Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer. Gynecol Oncol 81, 88-91 (2001). DOI: 10.1006/gyno.2000.6109
7. Lanciano, R. M., Pajak, T. F., Martz, K., Hanks, G. E. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. Int J Radiat Oncol Biol Phys 25, 391-397 (1993). DOI: 10.1016/0360-3016(93)90058-4
8. Mell, L. K., Kochanski, J. D., Roeske, J. C., Haslam, J. J., Mehta, N., Yamada, S. D., Hurteau, J. A., Collins, Y. C., Lengyel, E., Mundt, A. J. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys 66, 1356-1365 (2006). DOI: 10.1016/j.ijrobp.2006.03.018
9. Albuquerque, K., Giangreco, D., Morrison, C., Siddiqui, M., Sinacore, J., Potkul, R., Roeske, J. Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT. Int J Radiat Oncol Biol Phys 79, 1043-1047 (2011). DOI: 10.1016/j.ijrobp.2009.12.025
10. Roeske, J. C., Lujan, A., Rotmensch, J., Waggoner, S. E., Yamada, D., Mundt, A. J. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 48, 1613-1621 (2000). DOI: 10.1016/S0360-3016(00)00771-9
11. Brixey, C. J., Roeske, J. C., Lujan, A. E., Yamada, S. D., Rotmensch, J., Mundt, A. J. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 54, 1388-1396 (2002). DOI: 10.1016/S0360-3016(02)03801-4
12. Lujan, A. E., Mundt, A. J., Yamada, S. D., Rotmensch, J., Roeske, J. C. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys 57, 516-521 (2003). DOI: 10.1016/S0360-3016(03)00521-2
13. Mell, L. K., Tiryaki, H., Ahn, K. H., Mundt, A. J., Roeske, J. C., Aydogan, B. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys 71, 1504-1510 (2008). DOI: 10.1016/j.ijrobp.2008.04.046
14. Ellis, R. E. The distribution of active bone marrow in the adult. 14. Phys Med Biol 5, 255-258 (1961). DOI: 10.1088/0031-9155/5/3/302
15. Portelance, L., Moughan, J., Jhingran A., Miller, B. E., Salehpour, M. R., D'Souza, D., Haddock, M., Rotman, M. A Phase II Multi-institutional Study of Postoperative Pelvic Intensity Modulated Radiation Therapy (IMRT) with Weekly Cisplatin in Patients with Cervical Carcinoma: Two Year Efficacy Results of the RTOG 0418. Int J Radiat Oncol Biol Phys 81, S3 (2011). DOI: 10.1016/j.ijrobp.2011.06.007
16. Portelance, L., Winter, K., Jhingran, A., Miller, B. E., Salehpour, M. R., D'Souza, D. P., Haddock, M., Rotman, M., Gaffney, D. K. Post-operative Pelvic Intensity Modulated Radiation Therapy (IMRT) with Chemotherapy for Patients with Cervical Carcinoma/RTOG 0418 Phase II Study. Int J Radiat Oncol Biol Phys 75, S640-641 (2009). DOI: 10.1016/j.ijrobp.2009.07.1462
17. Jingran, A., Winter, K., Portelance, L., Miller, B. E., Salehpour, M. R., Gaur, R., Souhami, L., Small, W., Gaffney, D. Efficacy and Safety of IMRT after Surgery in Patients with Endometrial Cancer: RTOG 0418 Phase II Study. Int J Radiat Oncol Biol Phys 81, S45 (2011). DOI: 10.1016/j.ijrobp.2011.06.091
18. Klopp, A. H., Moughan, J., Portelance, L., Miller, B. E., Salehpour, M. R., D'Souza, D., Souhami, L., Small, W., Gaur, R., Jhingran, A. Hematologic toxicity on RTOG 0418: A Phase II Study of Post-operative IMRT for Gynecolgic Cancer. Int J Radiat Oncol Biol Phys 78, S121 (2010). DOI: 10.1016/j.ijrobp.2010.07.307
19. Rose, R. S., Bulent, A., Liang, Y., Yeginer, M., Hasselle, M. D., Dandekar, V., Bafana, R., Yashar, C. M., Mundt, A. J., Roeske, J. C., Mell, L. K. Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicty in Cervical Cancer Patients Treated with Chemotherapy. Int J Radiat Oncol Biol Phys 79, 800-807 (2011). DOI: 10.1016/j.ijrobp.2009.11.010
20. Hayman, J. A., Callahan, J. W., Herschtal, A., Everitt, S., Binns, D.S., Hicks, R. J., Mac Manus, M. Distribution of Proliferating Bone Marrow in Adult Cancer Patients Determined Using FLT-PET Imaging. Int J Radiat Oncol Biol Phys 79, 847-852 (2011). DOI: 10.1016/j.ijrobp.2009.11.040
21. McGuire, S. M., Menda, Y., Ponto, L. L., Juweid, M., Buatti, J., Bayouth, J. E. A Methodology for Incorporating Functional Bone Marrow Sparing in IMRT Planning for Pelvic Radiation Therapy. Radiother Oncol 99, 49-54 (2011). DOI: 10.1016/j.radonc.2011.01.025
22. Mundt, A. J., Roeske, J. C., Lujan, A. E. Intensity-modulated radiation therapy in gynecologic malignancies. Med Dosim 27, 131-136 (2002). DOI: 10.1016/S0958-3947(02)00095-X